06:22:05 EDT Fri 10 Jul 2020
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Z:PFE - PFIZER INC - http://www.pfizer.com06:22:05 EDT
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PFE - Z0.333.21·33.400.133.46-0.93.812546    44.105  27.8806:01:45Jul 0915 min RT 2¢

Recent Trades - Last 10 of 46
Time ETExPriceChangeVolume
06:01:45Z33.40-0.061
05:55:44Z33.33-0.1319
05:55:44Z33.33-0.1321
05:55:44Z33.35-0.115
05:55:44Z33.35-0.111
05:55:44Z33.40-0.062
05:55:44Z33.40-0.0659
05:40:27Z33.33-0.131
05:32:50Z33.30-0.16100
05:32:50Z33.30-0.16400

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent BulletinsNews ReleasesIn The NewsOther
Date ETSymbolTypeHeadline
2020-07-09 09:03U:PFENews Release    Pfizer Pledges $100 Million to New Industry Fund to Help Fight Growing Threat of Antimicrobial Resistance
2020-07-01 09:01U:PFENews ReleasePfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2
2020-06-30 18:45U:PFENews ReleaseFDA Approves BAVENCIO as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial Carcinoma
2020-06-25 12:14U:PFENews ReleasePfizer Declares Third-Quarter 2020 Dividend
2020-06-24 07:00U:PFENews ReleasePfizer and Wellcome Launch Surveillance Program to Combat Growing Threat of Antimicrobial Resistance in Sub-Saharan Africa
2020-06-22 08:00U:PFENews ReleasePfizer Announces Start of Four Phase 3 Clinical Trials for Investigational Vaccines
2020-06-18 09:00U:PFENews ReleasePfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels and No Bleeding Events or Factor Usage in 3e13 vg/kg Cohort Following giroctocogene fitelparvovec (SB-525) Gene Therapy
2020-06-18 06:59U:PFENews ReleaseUpjohn Announces Pricing of Senior Notes in Connection with the Proposed Combination of Mylan and Upjohn
2020-06-16 13:15U:PFENews ReleaseMerck and Pfizer ’s SGLT2 Inhibitor STEGLATROTM (ertugliflozin) Meets Primary Endpoint in VERTIS CV Trial for Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
2020-06-16 10:00U:PFENews ReleasePfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with Analysts
2020-06-12 10:00U:PFENews ReleasePfizer Invites Public to View and Listen to Webcast of June 18 Conference Call with Analysts to Review Data Presentations at Scientific Conferences during the Week of June 15th